Human Reproduction, Vol. 15, No. 5, 1086-1091,
May 2000
© 2000 European Society of Human Reproduction and Embryology
The measurement of endometrial perfusion in Norplant users: a pilot study
1 Imperial College School of Medicine at St Mary's, Norfolk Place, London W2 1PG, UK, 2 Department of Anatomy and Histology, Flinders University of South Australia, Adelaide, South Australia, 3 Sydney Centre for Reproductive Health Research, Department of Obstetrics and Gynaecology, University of Sydney, NSW and 4 Electron Microscope Department, University of Sydney, NSW, Australia
The use of progestogens without oestrogen is commonly associated with irregular menstrual bleeding. Oestrogens and progestogens are both thought to influence endometrial perfusion; changes in endometrial perfusion may contribute to vascular fragility and breakdown. In this study, endometrial perfusion was measured using laser-Doppler fluxmetry in women in the secretory phase of the menstrual cycle before and 46 weeks after insertion of the low-dose long-acting levonorgestrel contraceptive implant system, Norplant. Endometrial perfusion was also measured in women exposed to Norplant for up to 19 months. There was no significant difference between endometrial perfusion in control cycles (27.2 flux units ± 5.5, SEM) and at 46 weeks after Norplant insertion (16.3 flux units ± 5.0), a time when irregular bleeding and spotting are common. Endometrial perfusion was no different from controls after longer periods of Norplant exposure (35.7 flux units ± 7.2). No direct relationships between endometrial perfusion and plasma concentrations of ovarian steroid hormones were demonstrated. Short-term endometrial vasomotion was largely abolished during Norplant exposure.
Key words: endometrium/Norplant/perfusion/progestogens/vaso-motion
5 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Hickey, G. Krikun, P. Kodaman, F. Schatz, C. Carati, and C. J. Lockwood Long-Term Progestin-Only Contraceptives Result in Reduced Endometrial Blood Flow and Oxidative Stress J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3633 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey and I.S. Fraser Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding Hum. Reprod., September 1, 2002; 17(9): 2428 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Krikun, H. Critchley, F. Schatz, L. Wan, R. Caze, R. N. Baergen, and C. J. Lockwood Abnormal Uterine Bleeding during Progestin-Only Contraception May Result from Free Radical-Induced Alterations in Angiopoietin Expression Am. J. Pathol., September 1, 2002; 161(3): 979 - 986. [Abstract] [Full Text] [PDF] |
||||


